Lange A - Search Results

1

The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.

Lange A, Jaskula E, Lange J, Dworacki G, Nowak D, Simiczyjew A, Mordak-Domagala M, Sedzimirska M. Lange A, et al. Among authors: lange j. PLoS One. 2018 Jan 5;13(1):e0190525. doi: 10.1371/journal.pone.0190525. eCollection 2018. PLoS One. 2018. PMID: 29304116 Free PMC article.

2

Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.

Jaskula E, Dlubek D, Tarnowska A, Lange J, Mordak-Domagala M, Suchnicki K, Sedzimirska M, Borowik A, Mizia S, Lange A. Jaskula E, et al. Among authors: lange j, lange a. Viruses. 2015 Mar 23;7(3):1391-408. doi: 10.3390/v7031391. Viruses. 2015. PMID: 25807050 Free PMC article.

3

Intra-bone donor lymphocyte infusion at relapse: clinical outcome is associated with presence of CD8+ cells in the marrow.

Lange A, Wodzińska-Maszko I, Pakos H, Sobczyńska-Konefał A, Lange J, Mordak-Domagała M, Bocheńska J, Jaskuła E. Lange A, et al. Among authors: lange j. Bone Marrow Transplant. 2020 May;55(5):974-978. doi: 10.1038/s41409-019-0632-z. Epub 2019 Aug 27. Bone Marrow Transplant. 2020. PMID: 31455896 Free PMC article. No abstract available.

4

CD14 + HLADR - blood values in patients after alloHSCT are highly predictive of survival and infectious complications.

Jaskuła E, Lange J, Sędzimirska M, Suchnicki K, Mordak-Domagała M, Pakos H, Lange A. Jaskuła E, et al. Among authors: lange j, lange a. Transpl Immunol. 2021 Apr;65:101370. doi: 10.1016/j.trim.2021.101370. Epub 2021 Jan 20. Transpl Immunol. 2021. PMID: 33484872

5

Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients.

Lange A, Lange J, Jaskuła E. Lange A, et al. Among authors: lange j. Front Immunol. 2021 Jun 2;12:658896. doi: 10.3389/fimmu.2021.658896. eCollection 2021. Front Immunol. 2021. PMID: 34149697 Free PMC article. Review.

6

The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation.

Bogunia-Kubik K, Mlynarczewska A, Jaskula E, Lange A. Bogunia-Kubik K, et al. Among authors: lange a. Br J Haematol. 2006 Feb;132(3):326-32. doi: 10.1111/j.1365-2141.2005.05875.x. Br J Haematol. 2006. PMID: 16409297 Free article.

7

NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.

Jaskula E, Lange A, Kyrcz-Krzemien S, Markiewicz M, Dzierzak-Mietla M, Jedrzejczak WW, Czajka P, Mordak-Domagala M, Lange J, Gronkowska A, Nowak J, Warzocha K, Hellmann A, Kowalczyk J, Drabko K, Gozdzik J, Mizia S; Polish Donor-Recipient Matching Group. Jaskula E, et al. Among authors: lange j, lange a. Biol Blood Marrow Transplant. 2014 Mar;20(3):409-14. doi: 10.1016/j.bbmt.2013.12.558. Epub 2013 Dec 15. Biol Blood Marrow Transplant. 2014. PMID: 24345423 Free article.

8

Donor lymphocyte infusions to leukemic bone lesions are therapeutically effective in a Ph+ ALL patient with post-HSCT relapse.

Lange A, Dlubek D, Zdziarski R, Chodorowska A, Mordak-Domagala M, Klimczak A, Lange J, Jaskula E. Lange A, et al. Among authors: lange j. J Immunotoxicol. 2014 Oct;11(4):347-52. doi: 10.3109/1547691X.2014.893042. Epub 2014 Mar 10. J Immunotoxicol. 2014. PMID: 24611731 Free article.

9

Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.

Lange A, Jaskula E, Lange J, Dworacki G, Nowak D, Simiczyjew A, Mordak-Domagala M, Sedzimirska M. Lange A, et al. Among authors: lange j. PLoS One. 2018 Dec 6;13(12):e0209108. doi: 10.1371/journal.pone.0209108. eCollection 2018. PLoS One. 2018. PMID: 30521628 Free PMC article.

10

Diverse Activity of IL-17⁺ Cells in Chronic Skin and Mucosa Graft-Versus-Host Disease.

Klimczak A, Suchnicki K, Sedzimirska M, Lange A. Klimczak A, et al. Among authors: lange a. Arch Immunol Ther Exp (Warsz). 2019 Oct;67(5):311-323. doi: 10.1007/s00005-019-00549-2. Epub 2019 Jun 8. Arch Immunol Ther Exp (Warsz). 2019. PMID: 31177288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,635 results

Search Page

Filters